The European Medicines Agency (EMA) has validated Chiesi Global Rare Diseases and Protalix BioTherapeutics’ submission to ...

Located on the outskirts of the historic Italian city – home to Verdi and myriad architectural gems – the press launch and tour of the €85 million Chiesi development was a quintessentially ...

Chiesi, which is best known for its respiratory drugs, said it has created a new unit based in Boston, Massachusetts, one of the biggest bioscience hub cities in the US.

Protalix BioTherapeutics, Inc. (NYSE-American: PLX), a biopharmaceutical company focused on the development, production and commercialization of recombinant therapeutic proteins produced by its ...

(RTTNews) - Chiesi Global Rare Diseases, a unit of Chiesi Group, and Protalix BioTherapeutics announced the European Medicines Agency has validated the Variation Submission for pegunigalsidase ...

Since opening its doors in 1981, Nohra Haime Gallery has been recognized for its consistent representation of International, Latin American, sculpture and women artists, often exhibiting work that ...

© 2024 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and ...

Chiesi Global Rare Diseases and Protalix (PLX) announced that the European Medicines Agency, or EMA, has validated the Variation Submission for ...